Cibc World Markets Corp Raises Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cibc World Markets Corp boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 64,026 shares of the medical equipment provider’s stock after buying an additional 8,100 shares during the period. Cibc World Markets Corp’s holdings in Intuitive Surgical were worth $33,419,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Atala Financial Inc purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $25,000. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $28,000. Kohmann Bosshard Financial Services LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $31,000. Finally, MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical in the 3rd quarter valued at about $33,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 1.6 %

Shares of ISRG opened at $484.44 on Monday. The stock has a 50 day moving average price of $567.46 and a 200 day moving average price of $531.94. The company has a market capitalization of $172.55 billion, a price-to-earnings ratio of 75.58, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Insider Activity at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 over the last three months. 0.90% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on ISRG shares. Stifel Nicolaus lifted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. BTIG Research lifted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Finally, UBS Group lifted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.